Early diagnosis of a condition as severe as cancer is the only key to its early treatment. One undeniable fact about cervical cancer is that regular visual inspection of the cervix is imperative for satisfactorily identifying the location, extent and type of disease. In rural settings however, it can be difficult to reach a doctor on time, every time for a routine checkup.
Telehealth offers promising developments in implementing cost effective cervical cancer screenings for women in remote locations. These cervical screenings can help timely detect and remove abnormal cells or tissues in the cervix, before cancer takes hold. This secondary prevention of cervical cancer can help save thousands of lives.
The Telehealth Connection
In developing nations, especially remote locations, cervical cancer screenings are carried out using a method called Visual Inspection with Acetic Acid (VIA).
Monitoring evaluation and implementation of such screening programs can be challenging in usual circumstances, but in developing areas it becomes even more problematic. While there are other widely-used methods of cervical cancer screenings, such as Pap smear, VIA is widely gaining fame for having a high patient acceptance, low-cost screening alternative.
It is already practiced by healthcare providers in over 70 countries around the world.
The EVA system promises to revolutionize the way cervical cancer screenings are carried out in remote locations. EVA or Enhanced Visual Assessment system was developed to augment the VIA processes in remote and/or low-resource settings. With EVA, it becomes possible to turn a smartphone into a mobile colposcope and a diagnosis device as it takes and uploads pictures to an image portal for diagnosis later on.
This real-time screening and diagnosis of cervical cancer, enabled by smart, telehealth-powered diagnostic medical devices holds promise for broader use in screening programs in remote settings.
Telehealth Is Making Cervical Cancer Screenings Cheaper And Faster!
Cervical cancer is a principal cause of death among women. However, regular screenings and quicker diagnosis of cervical cancer can lead to reduced mortality rates across the world. Fortunately, it is a slow to develop disease and early diagnosis is key to early treatment if cervical cancer. EVA can apply to virtually any setting for less than $28 USD, ensuring faster identification of visual markers for dangerous developments.
If you’d like to learn more about the EVA Scope and in-depth results of a Visual-Based Cervical Cancer Screening Program, Check out this in-depth article “Results from a Visual-Based Cervical Cancer Screening Program” recently published in Telehealth and Medicine Today™, an online open access digital journal for the telemedicine industry.